Seeks to further amend notification No. 16/2017-Customs dated 20th April, 2017, which provides exemption to specified medicines under certain Patient Assistance Programmes (PAPs) run by pharmaceutical companies - 41/2020 - Customs -Tariff
📋
Contents
Cases Cited
Referred In
Notifications
Circulars
Forms
Manuals
Acts
Rules & Regulations
Case Laws New
Ref Provisions New
Plus +
Source NTF
Summary
Similar
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Exemption for Patient Assistance Programmes expands to include specified PAPs and named pharmaceutical manufacturers under customs rules. Amendment to the customs exemption notification substitutes table entries to add specified Patient Assistance Programmes and their pharmaceutical manufacturers, thereby extending the existing exemption for imported medicines to the listed PAPs and named companies under the powers conferred by section 25(1) of the Customs Act, 1962.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Exemption for Patient Assistance Programmes expands to include specified PAPs and named pharmaceutical manufacturers under customs rules.
Amendment to the customs exemption notification substitutes table entries to add specified Patient Assistance Programmes and their pharmaceutical manufacturers, thereby extending the existing exemption for imported medicines to the listed PAPs and named companies under the powers conferred by section 25(1) of the Customs Act, 1962.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.